Etol, Jance Domenic B.
HRN: 26-24-05 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/18/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/18/2024
11/24/2024
IVT
2.25g
Q6
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes